Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02315885 · ClinicalTrials.gov registry record · NA

Biomarkers to Measure Treatment Response for Alcohol Dependence

A NA study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT02315885 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02315885, a NA study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The purpose of the research study of the K23 award is to develop a blood test that can check how much alcohol a person has consumed in the past few days. We will enroll heavy social drinkers who do not have alcohol-related problems but used to drinking 5 or more beers on a single occasion. Both men and women between ages 21 and 65 years can join the study. All participants must be of European decent.

Interventions

  • OTHER Alcohol administration; Placebo administration

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2015-07
Est. Completion 2019-12-31
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT02315885

The ClinicalTrials.gov registry entry for NCT02315885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Alcohol administration; Placebo administration is the first listed.

NCT02315885 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02315885 about?

NCT02315885 is a clinical study titled "Biomarkers to Measure Treatment Response for Alcohol Dependence". The purpose of the research study of the K23 award is to develop a blood test that can check how much alcohol a person has consumed in the past few days. We will enroll heavy social drinkers who do not have alcohol-related problems but used to drinking 5 or more beers on a single occasion. Both men ...

What is the current status of trial NCT02315885?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2015-07. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT02315885?

The interventions under investigation include: Alcohol administration; Placebo administration (OTHER).

Who is sponsoring clinical trial NCT02315885?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.